21st.BIO

Europe, Hovedstaden, Denmark, Virum

Description

21st Bio has the potential to replace and improve a wide range of meals and materials with appealing sustainable bio-based alternatives.

Investor Profile

21st.BIO has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

Concentrates on Series A rounds (top funding stages).
Majority of deals are located in Denmark.
Strong thematic focus on Biotechnology, Industrial Automation, Machine Learning.

Stage Focus

Series A (100%)

Country Focus

Denmark (100%)

Industry Focus

Biotechnology
Industrial Automation
Machine Learning
Robotics

FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does 21st.BIO frequently co-invest with?

Astanor Ventures

Astanor Ventures

Europe, Luxembourg, Belgium, Luxembourg

Co-Investments: 1

ACME Capital

North America, Florida, United States, Boca Raton

Co-Investments: 1

Y Combinator

North America, California, United States, Mountain View

Co-Investments: 1

R7 Partners

North America, Illinois, United States, Chicago

Co-Investments: 1

Which angels does 21st.BIO often collaborate with?

Europe, Hovedstaden, Denmark, Copenhagen

Shared Deals: 1

Nicholas Francis

Europe, Hovedstaden, Denmark, Copenhagen

Shared Deals: 1

What are some of recent deals done by 21st.BIO?

Reshape Biotech

Kongens Lyngby, Hovedstaden, Denmark

Reshape Biotech builds lab robots that automate the everyday tasks of microbiologists, from filling plates to analyzing images.

BiotechnologyIndustrial AutomationMachine LearningRobotics

Series AApr 9, 2024

Amount Raised: $20,000,000